CA
ANGO icon

Clearstead Advisors’s AngioDynamics ANGO Stock Holding History

Clearstead Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$808 Buy
+62
New +$706 ﹤0.01% 2767
2026
Q1 		– Sell
-14
Closed -$180 – 2276
2025
Q4 		$180 Sell
14
-519
-97% -$6.41K ﹤0.01% 2439
2025
Q3 		$5.95K Hold
533
– – ﹤0.01% 2090
2025
Q2 		$5.29K Buy
+533
New +$5.22K ﹤0.01% 2095

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Advisors's ANGO Position: Q2 2026 in Review

Clearstead Advisors opened a new position in AngioDynamics (ANGO) in Q2 2026: 62 shares worth $808. The stake represents ﹤0.01% of the portfolio and ranks #2767 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ANGO as recently as Q4 2025.

Clearstead Advisors first reported a position in ANGO in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.95K in Q3 2025. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Clearstead Advisors held 62 shares of AngioDynamics worth $808 as of Q2 2026.
  • AngioDynamics was a new Clearstead Advisors position in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2767 holding.
  • Clearstead Advisors first reported a position in AngioDynamics in Q2 2025 and has held it in 4 quarters since.
  • Clearstead Advisors's AngioDynamics position peaked at $5.95K in Q3 2025.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.